{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:47:30Z","timestamp":1785235650287,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Expertise France-L'Initiative","award":["N\u00b0 20SANIN204"],"award-info":[{"award-number":["N\u00b0 20SANIN204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Plasmodium falciparum<\/jats:italic> malaria remains a major public health concern in sub-Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine + sulfadoxine-pyrimethamine is one of the most important preventive interventions. Despite its implementation, the burden of malaria is still very high in children under five years old in Burkina Faso, suggesting that the expected impact of this promising strategy might not be attained. Development of innovative strategies to improve the efficacy of these existing malaria control measures is essential. In such context, we postulate that screening and treatment of malaria in household members of children receiving SMC could greatly improve the impact of SMC intervention and reduce malaria transmission in endemic settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This randomized superiority trial will be carried out in the Nanoro health district, Burkina Faso. The unit of randomisation will be the household and all eligible children from a household will be allocated to the same study group. Households with 3\u201359\u2009months old children will be assigned to either (i) control group (SMC alone) or (ii) intervention (SMC+ screening of household members with standard Histidin Rich Protein Rapid Diagnostic Test (HRP2-RDT) and treatment if positive). The sample size will be 526 isolated households per arm, i.e., around 1052 children under SMC coverage and an expected 1315 household members. Included children will be followed-up for 24\u2009months to fully cover two consecutive malaria transmission seasons and two SMC cycles. Children will be actively followed-up during the malaria transmission seasons while in the dry seasons the follow-up will be passive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study will respond to a major public health concern by providing evidence of the efficacy of an innovative strategy to boost the impact of SMC intervention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13690-022-00800-x","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T03:02:43Z","timestamp":1643252563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial"],"prefix":"10.1186","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-3367","authenticated-orcid":false,"given":"Paul","family":"Sondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Christian","family":"Tahita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidou","family":"Ilboudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toussaint","family":"Rouamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Derra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Tougri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice Marie Ad\u00e9la\u00efde","family":"Konseibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Roamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina Dahlstr\u00f6m","family":"Otienoburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9renger","family":"Kabor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalynn","family":"Kennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadija","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wend-Timbe-Noma Arlette Ra\u00efssa","family":"Zongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadima Yaya","family":"Bocoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dhorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"800_CR1","volume-title":"World malaria report 2019","author":"WHO","year":"2020","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2020."},{"key":"800_CR2","volume-title":"Plan strategique 2016\u20132020 de lutte contre le paludisme au Burkina Faso","author":"MOH","year":"2016","unstructured":"MOH. Plan strategique 2016\u20132020 de lutte contre le paludisme au Burkina Faso. Ouagadougou: Ministry of Health; 2016."},{"issue":"2","key":"800_CR3","doi-asserted-by":"publisher","first-page":"e16976","DOI":"10.1371\/journal.pone.0016976","volume":"6","author":"AL Wilson","year":"2011","unstructured":"Wilson AL. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One. 2011;6(2):e16976. https:\/\/doi.org\/10.1371\/journal.pone.0016976.","journal-title":"PLoS One"},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"CD003756","DOI":"10.1002\/14651858.CD003756.pub4","volume":"2","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2:CD003756. https:\/\/doi.org\/10.1002\/14651858.CD003756.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"800_CR5","volume-title":"WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO","year":"2012","unstructured":"WHO. WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012."},{"issue":"1","key":"800_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12913-019-4299-3","volume":"19","author":"G Kombate","year":"2019","unstructured":"Kombate G, Guiella G, Baya B, Serme L, Bila A, Haddad S, et al. Analysis of the quality of seasonal malaria chemoprevention provided by community health Workers in Boulsa health district, Burkina Faso. BMC Health Serv Res. 2019;19(1):472. https:\/\/doi.org\/10.1186\/s12913-019-4299-3.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"800_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4269\/ajtmh.17-0599","volume":"98","author":"T Druetz","year":"2018","unstructured":"Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, et al. Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a quasi-experimental study in Burkina Faso. Am J Trop Med Hyg. 2018;98(2):524\u201333. https:\/\/doi.org\/10.4269\/ajtmh.17-0599.","journal-title":"Am J Trop Med Hyg"},{"issue":"10265","key":"800_CR8","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"E Baba","year":"2020","unstructured":"Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and Central Africa: an observational study. Lancet. 2020;396(10265):1829\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(20)32227-3.","journal-title":"Lancet."},{"issue":"5","key":"800_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4269\/ajtmh.2007.77.939","volume":"77","author":"MP Dal-Bianco","year":"2007","unstructured":"Dal-Bianco MP, K\u00f6ster KB, Kombila UD, Kun JF, Grobusch MP, Ngoma GM, et al. High prevalence of asymptomatic plasmodium falciparum infection in Gabonese adults. Am J Trop Med Hyg. 2007;77(5):939\u201342. https:\/\/doi.org\/10.4269\/ajtmh.2007.77.939.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"800_CR10","doi-asserted-by":"publisher","first-page":"e20805","DOI":"10.1371\/journal.pone.0020805","volume":"6","author":"S Karl","year":"2011","unstructured":"Karl S, Gurarie D, Zimmerman PA, King CH, Pierre TGS, Davis TM. A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS One. 2011;6(6):e20805. https:\/\/doi.org\/10.1371\/journal.pone.0020805.","journal-title":"PLoS One"},{"issue":"5","key":"800_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/ije\/dys159","volume":"41","author":"K Derra","year":"2012","unstructured":"Derra K, Rouamba E, Kazienga A, Ouedraogo S, Tahita MC, Sorgho H, et al. Profile: Nanoro health and demographic surveillance system. Int J Epidemiol. 2012;41(5):1293\u2013301. https:\/\/doi.org\/10.1093\/ije\/dys159.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"800_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2875-5-70","volume":"5","author":"C Frey","year":"2006","unstructured":"Frey C, Traor\u00e9 C, De Allegri M, Kouyat\u00e9 B, M\u00fcller O. Compliance of young children with ITN protection in rural Burkina Faso. Malar J. 2006;5(1):70. https:\/\/doi.org\/10.1186\/1475-2875-5-70.","journal-title":"Malar J"},{"issue":"11","key":"800_CR13","doi-asserted-by":"publisher","first-page":"e1002175","DOI":"10.1371\/journal.pmed.1002175","volume":"13","author":"B Ciss\u00e9","year":"2016","unstructured":"Ciss\u00e9 B, Ba EH, Sokhna C, NDiaye JL, Gomis JF, Dial Y, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13(11):e1002175. https:\/\/doi.org\/10.1371\/journal.pmed.1002175.","journal-title":"PLoS Med"},{"issue":"3","key":"800_CR14","doi-asserted-by":"publisher","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","volume":"11","author":"P Sondo","year":"2016","unstructured":"Sondo P, Derra K, Nakanabo SD, Tarnagda Z, Kazienga A, Zampa O, et al. Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso. PLoS One. 2016;11(3):e0151565. https:\/\/doi.org\/10.1371\/journal.pone.0151565.","journal-title":"PLoS One"},{"issue":"4","key":"800_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4269\/ajtmh.2007.76.608","volume":"76","author":"H Tinto","year":"2007","unstructured":"Tinto H, Ouedraogo JB, Zongo I, Van Overmeir C, Van Marck E, Guiguemde TR, et al. Sulfadoxine\u2013pyrimethamine efficacy and selection of plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007;76(4):608\u201313. https:\/\/doi.org\/10.4269\/ajtmh.2007.76.608.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"800_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12889-019-6565-z","volume":"19","author":"T Rouamba","year":"2019","unstructured":"Rouamba T, Nakanabo-Diallo S, Derra K, Rouamba E, Kazienga A, Inoue Y, et al. Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso. BMC Public Health. 2019;19(1):249. https:\/\/doi.org\/10.1186\/s12889-019-6565-z.","journal-title":"BMC Public Health"},{"key":"800_CR17","volume-title":"Annuaire statistique 2016","author":"MOH","year":"2017","unstructured":"MOH. Annuaire statistique 2016. Ouagadougou: Ministry of Health of Burkina Faso; 2017."},{"key":"800_CR18","volume-title":"Annuaire statistique 2017","author":"MOH","year":"2018","unstructured":"MOH. Annuaire statistique 2017. Ouagadougou: Ministry of Health of Burkina Faso; 2018."},{"key":"800_CR19","volume-title":"Annuaire statistique 2018","author":"MOH","year":"2019","unstructured":"MOH. Annuaire statistique 2018. Ouagadougou: Ministry of Health of Burkina Faso; 2019."},{"issue":"1","key":"800_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03249-x","volume":"19","author":"MR Ansbro","year":"2020","unstructured":"Ansbro MR, Jacob CG, Amato R, Kekre M, Amaratunga C, Sreng S, et al. Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2\/3 copy number variation in plasmodium falciparum. Malar J. 2020;19(1):1\u201310. https:\/\/doi.org\/10.1186\/s12936-020-03249-x.","journal-title":"Malar J"},{"key":"800_CR21","volume-title":"National guidelines for malaria cases management in Burkina Faso","author":"MOH","year":"2017","unstructured":"MOH. National guidelines for malaria cases management in Burkina Faso. Ouagadougou: Ministry of Health of Burkina Faso; 2017."},{"issue":"10","key":"800_CR22","doi-asserted-by":"publisher","first-page":"e0164851","DOI":"10.1371\/journal.pone.0164851","volume":"11","author":"AM Kabanywanyi","year":"2016","unstructured":"Kabanywanyi AM, Baiden R, Ali AM, Mahende MK, Ogutu BR, Oduro A, et al. Multi-country evaluation of safety of dihydroartemisinin\/piperaquine post-licensure in african public hospitals with electrocardiograms. PLoS One. 2016;11(10):e0164851. https:\/\/doi.org\/10.1371\/journal.pone.0164851.","journal-title":"PLoS One"},{"issue":"11","key":"800_CR23","doi-asserted-by":"publisher","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","volume":"4","author":"Q Bassat","year":"2009","unstructured":"Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Men\u00e9ndez C, et al. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One. 2009;4(11):e7871. https:\/\/doi.org\/10.1371\/journal.pone.0007871.","journal-title":"PLoS One"},{"issue":"9","key":"800_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/319865","volume":"183","author":"G Dorsey","year":"2001","unstructured":"Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001;183(9):1417\u201320. https:\/\/doi.org\/10.1086\/319865.","journal-title":"J Infect Dis"},{"issue":"6","key":"800_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1086\/514159","volume":"176","author":"CV Plowe","year":"1997","unstructured":"Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, et al. Mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis. 1997;176(6):1590\u20136. https:\/\/doi.org\/10.1086\/514159.","journal-title":"J Infect Dis"},{"issue":"2","key":"800_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2017 Feb;17(2):164\u201373. https:\/\/doi.org\/10.1016\/S1473-3099(16)30409-1.","journal-title":"Lancet Infect Dis"},{"issue":"7481","key":"800_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant plasmodium falciparum malaria. Nature. 2014;505(7481):50\u20135. https:\/\/doi.org\/10.1038\/nature12876.","journal-title":"Nature."}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-022-00800-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T03:03:15Z","timestamp":1643252595000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-022-00800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1186\/s13690-022-00800-x","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study will be carried out in compliance with ethical principles and relevant regulations in Burkina Faso. The protocol has been registered in  with identifier . The SMC-RST study protocol was approved by the Ethical Committee for health research in Burkina Faso (Deliberation N\u00b02021\u201303-059, March 10th, 2021). The local community will be informed on the purpose of the study through the community leaders and a general consent will be obtained before starting the sudy. All eligible households will receive in advance a copy of the study information sheet and the consent form from community health workers which they are welcome to discuss with all the households members and friends. A signed\/thumb printed inform consent will be obtained from all participants before enrolment. For children, the parents or guardians will be asked to sign the consent to participate in the study. In addition to the consent obtained from parents \/ guardians, an assent will be obtained from adolescents (10 to 19\u2009years old). A signature from an impartial adult witness present during the informed consent discussion and a thumb print of the parent\/guardian will be obtained in cases where parents \/ guardians are illiterate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}